Amphetamine
Amphetamine may decrease the sedative activities of Roxatidine acetate.
Atazanavir
The serum concentration of Atazanavir can be decreased when it is combined with Roxatidine acetate.
Benzphetamine
Benzphetamine may decrease the sedative activities of Roxatidine acetate.
Advertisement
Benzylpenicilloyl polylysine
Roxatidine acetate may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.
BETAHISTINE
The therapeutic efficacy of Betahistine can be decreased when used in combination with Roxatidine acetate.
Bosutinib
The serum concentration of Bosutinib can be decreased when it is combined with Roxatidine acetate.
Advertisement
Bosutinib monohydrate
The serum concentration of Bosutinib can be decreased when it is combined with Roxatidine acetate.
Cefditoren
The serum concentration of Cefditoren can be decreased when it is combined with Roxatidine acetate.
Cefpodoxime
Roxatidine acetate can cause a decrease in the absorption of Cefpodoxime resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Cefuroxime
Roxatidine acetate can cause a decrease in the absorption of Cefuroxime resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cysteamine
The therapeutic efficacy of Cysteamine can be decreased when used in combination with Roxatidine acetate.
Dabrafenib
The serum concentration of Dabrafenib can be decreased when it is combined with Roxatidine acetate.
Dasatinib
Roxatidine acetate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dasatinib Anhydrous
Roxatidine acetate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Delavirdine
Roxatidine acetate can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dexmethylphenidate
Roxatidine acetate can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Dextroamphetamine
Dextroamphetamine may decrease the sedative activities of Roxatidine acetate.
Diethylpropion
Diethylpropion may decrease the sedative activities of Roxatidine acetate.
Erlotinib
The serum concentration of Erlotinib can be decreased when it is combined with Roxatidine acetate.
Ferric Carboxymaltose
Roxatidine acetate can cause a decrease in the absorption of Ferric Carboxymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric Pyrophosphate
Roxatidine acetate can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fosamprenavir
The serum concentration of Fosamprenavir can be decreased when it is combined with Roxatidine acetate.
Gefitinib
The serum concentration of Gefitinib can be decreased when it is combined with Roxatidine acetate.
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Roxatidine acetate.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Roxatidine acetate.
Indinavir
The serum concentration of Indinavir can be decreased when it is combined with Roxatidine acetate.
INDINAVIR ANHYDROUS
The serum concentration of Indinavir can be decreased when it is combined with Roxatidine acetate.
Iron
Roxatidine acetate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Roxatidine acetate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Sucrose
Roxatidine acetate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron-Dextran Complex
Roxatidine acetate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Itraconazole
The serum concentration of Itraconazole can be decreased when it is combined with Roxatidine acetate.
Ketoconazole
The serum concentration of Ketoconazole can be decreased when it is combined with Roxatidine acetate.
Ledipasvir
The serum concentration of Ledipasvir can be decreased when it is combined with Roxatidine acetate.
Lisdexamfetamine
Lisdexamfetamine may decrease the sedative activities of Roxatidine acetate.
Lisdexamfetamine Dimesylate
Lisdexamfetamine may decrease the sedative activities of Roxatidine acetate.
Mephentermine
Mephentermine may decrease the sedative activities of Roxatidine acetate.
Mesalamine
The therapeutic efficacy of Mesalazine can be decreased when used in combination with Roxatidine acetate.
Methamphetamine
Methamphetamine may decrease the sedative activities of Roxatidine acetate.
Methylphenidate
Roxatidine acetate can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Nelfinavir
The serum concentration of Nelfinavir can be decreased when it is combined with Roxatidine acetate.
Nilotinib
The serum concentration of Nilotinib can be decreased when it is combined with Roxatidine acetate.
p-Hydroxyamphetamine
Hydroxyamphetamine may decrease the sedative activities of Roxatidine acetate.
Pazopanib
Roxatidine acetate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Phentermine
Phentermine may decrease the sedative activities of Roxatidine acetate.
PHENTERMINE RESIN
Phentermine may decrease the sedative activities of Roxatidine acetate.
Posaconazole
The serum concentration of Posaconazole can be decreased when it is combined with Roxatidine acetate.
Pseudoephedrine
Pseudoephedrine may decrease the sedative activities of Roxatidine acetate.
Risedronate
Roxatidine acetate can cause an increase in the absorption of Risedronate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Risedronic Acid
Roxatidine acetate can cause an increase in the absorption of Risedronate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Saquinavir
The serum concentration of Saquinavir can be increased when it is combined with Roxatidine acetate.
Saquinavir Mesylate
The serum concentration of Saquinavir can be increased when it is combined with Roxatidine acetate.
Sucroferric Oxyhydroxide
Roxatidine acetate can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Varenicline
The serum concentration of Varenicline can be increased when it is combined with Roxatidine acetate.
